Ralf G Meyer
Overview
Explore the profile of Ralf G Meyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
457
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thevapalan A, Apeldoorn D, Kern-Isberner G, Meyer R, Nietzke M, Panholzer T
Stud Health Technol Inform
. 2023 Sep;
307:161-171.
PMID: 37697850
Representing knowledge in a comprehensible and maintainable way and transparently providing inferences thereof are important issues, especially in the context of applications related to artificial intelligence in medicine. This becomes...
2.
Wegner J, Weidenthaler-Barth B, Engelbert J, Knothe M, Braun C, Helbig D, et al.
Exp Dermatol
. 2021 Jul;
30(12):1814-1819.
PMID: 34223669
Graft-versus-host disease (GvHD) is a major complication following stem-cell or solid-organ transplantation. Accurate diagnosis of cutaneous GvHD is challenging, given that drug eruptions and viral rashes may present with similar...
3.
Cornely O, Robertson M, Haider S, Grigg A, Geddes M, Aoun M, et al.
J Antimicrob Chemother
. 2017 Oct;
72(12):3501.
PMID: 29029280
No abstract available.
4.
Cornely O, Robertson M, Haider S, Grigg A, Geddes M, Aoun M, et al.
J Antimicrob Chemother
. 2017 Sep;
72(12):3406-3413.
PMID: 28961714
Objectives: A two-part (Phase 1B/3), sequential, open-label, multicentre study evaluated the pharmacokinetics (PK) and safety of intravenous (iv) posaconazole given as antifungal prophylaxis to neutropenic patients with AML or myelodysplastic...
5.
Kirschey S, Flohr T, Wolf H, Frickhofen N, Gramatzki M, Link H, et al.
Br J Haematol
. 2014 Dec;
168(6):824-34.
PMID: 25546611
Salvage therapy followed by high-dose therapy (HDT) remains a mainstay for patients with relapsed lymphoma, however no optimal regimen has been defined. Here we report on the results of R-DexaBEAM...
6.
Thomas S, Klobuch S, Sommer M, van Ewijk R, Theobald M, Meyer R, et al.
Exp Hematol
. 2013 Oct;
42(1):28-38.e1-2.
PMID: 24120693
Current strategies in cellular immunotherapy of cancer and viral infections include the adoptive transfer of T cell receptor (TCR) and chimeric antigen receptor engineered T cells. When using transient RNA...
7.
Christopeit M, Kuss O, Finke J, Bacher U, Beelen D, Bornhauser M, et al.
J Clin Oncol
. 2013 Aug;
31(26):3259-71.
PMID: 23918951
Purpose: To evaluate the role of a second allogeneic hematopoietic stem-cell transplantation (HSCT2) given for relapsed acute leukemia (AL) after related or unrelated first hematopoietic stem-cell transplantation (HSCT1) and to...
8.
Pfeiffer T, Schleuning M, Mayer J, Haude K, Tischer J, Buchholz S, et al.
Haematologica
. 2012 Sep;
98(4):518-25.
PMID: 22983588
Based on molecular aberrations, in particular the NPM1 mutation (NPM1(mut)) and the FLT3 internal tandem duplication (Flt3-ITD), prognostic subgroups have been defined among patients with acute myeloid leukemia with normal...
9.
Relle M, Becker M, Meyer R, Stassen M, Schwarting A
Mol Carcinog
. 2012 Aug;
53(2):117-24.
PMID: 22930395
Recent studies of mammalian genomes suggest that alternative promoters are associated with various disorders, including cancer. Here we present an intronic promoter of the murine proteinase 3 gene, which drives...
10.
Kleemann P, Distler E, Wagner E, Thomas S, Klobuch S, Aue S, et al.
Haematologica
. 2011 Dec;
97(6):874-82.
PMID: 22207687
Background: After allogeneic hematopoietic stem-cell transplantation patients are at increased risk for herpes zoster as long as varicella-zoster virus specific T-cell reconstitution is impaired. This study aimed to identify immunodominant...